148 related articles for article (PubMed ID: 32651214)
1. Utilizing SEER Cancer Registries for Population-Based Cancer Survivor Epidemiologic Studies: A Feasibility Study.
Gallicchio L; Elena JW; Fagan S; Carter M; Hamilton AS; Hastert TA; Hunter LL; Li J; Lynch CF; Milam J; Millar MM; Modjeski D; Paddock LE; Reed AR; Moses LB; Stroup AM; Sweeney C; Trapido EJ; West MM; Wu XC; Helzlsouer KJ
Cancer Epidemiol Biomarkers Prev; 2020 Sep; 29(9):1699-1709. PubMed ID: 32651214
[TBL] [Abstract][Full Text] [Related]
2. Healthcare experience among older cancer survivors: Analysis of the SEER-CAHPS dataset.
Halpern MT; Urato MP; Lines LM; Cohen JB; Arora NK; Kent EE
J Geriatr Oncol; 2018 May; 9(3):194-203. PubMed ID: 29249645
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of collecting patient-generated health data to enhance cancer registry surveillance.
Mangold KN; Gallicchio L; Gaysynsky A; Kent EE; Constantine K; Hesse BW
J Cancer Surviv; 2021 Oct; 15(5):785-791. PubMed ID: 33400151
[TBL] [Abstract][Full Text] [Related]
4. Building the infrastructure for nationwide cancer surveillance and control--a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States).
Wingo PA; Jamison PM; Hiatt RA; Weir HK; Gargiullo PM; Hutton M; Lee NC; Hall HI
Cancer Causes Control; 2003 Mar; 14(2):175-93. PubMed ID: 12749723
[TBL] [Abstract][Full Text] [Related]
5. Examining colorectal cancer survivors' surveillance patterns and experiences of care: a SEER-CAHPS study.
Mollica MA; Enewold LR; Lines LM; Halpern MT; Schumacher JR; Hays RD; Gibson JT; Schussler N; Kent EE
Cancer Causes Control; 2017 Oct; 28(10):1133-1141. PubMed ID: 28866818
[TBL] [Abstract][Full Text] [Related]
6. Rationale, Procedures, and Response Rates for a Pilot Study to Sample Cancer Survivors for NCI's Health Information National Trends Survey: HINTS-SEER 2021.
Blake KD; Moser RP; Murray AB; Davis T; Cantor D; Caporaso A; West M; Bentler S; McKinley M; Shariff-Marco S; Wiggins C; Vanderpool RC
J Health Commun; 2024 Feb; 29(2):119-130. PubMed ID: 38131342
[TBL] [Abstract][Full Text] [Related]
7. Cancer survivor perspectives on sharing patient-generated health data with central cancer registries.
Smith TG; Dunn ME; Levin KY; Tsakraklides SP; Mitchell SA; van de Poll-Franse LV; Ward KC; Wiggins CL; Wu XC; Hurlbert M; Aaronson NK
Qual Life Res; 2019 Nov; 28(11):2957-2967. PubMed ID: 31399859
[TBL] [Abstract][Full Text] [Related]
8. Are cancer registries a viable tool for cancer survivor outreach? A feasibility study.
Carpentier MY; Tiro JA; Savas LS; Bartholomew LK; Melhado TV; Coan SP; Argenbright KE; Vernon SW
J Cancer Surviv; 2013 Mar; 7(1):155-63. PubMed ID: 23247719
[TBL] [Abstract][Full Text] [Related]
9. Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries.
Walker GV; Giordano SH; Williams M; Jiang J; Niu J; MacKinnon J; Anderson P; Wohler B; Sinclair AH; Boscoe FP; Schymura MJ; Buchholz TA; Smith BD
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):686-93. PubMed ID: 23773392
[TBL] [Abstract][Full Text] [Related]
10. Sampling in population-based cancer caregivers research.
Kim Y; Kashy DA; Kaw CK; Smith T; Spillers RL
Qual Life Res; 2009 Oct; 18(8):981-9. PubMed ID: 19655274
[TBL] [Abstract][Full Text] [Related]
11. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Young Adult Female Cancer Survivors Recruited from a Population-Based Cancer Registry to Eligible Survivors.
Howards PP; Mink PJ; Kim KH; Woodard JJ; Mertens AC
Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):727-735. PubMed ID: 33531434
[TBL] [Abstract][Full Text] [Related]
13. The evaluation of the data collection process for a multicenter, population-based, case-control design.
Wingo PA; Ory HW; Layde PM; Lee NC
Am J Epidemiol; 1988 Jul; 128(1):206-17. PubMed ID: 3381827
[TBL] [Abstract][Full Text] [Related]
14. Coding completeness and quality of relative survival-related variables in the National Program of Cancer Registries Cancer Surveillance System, 1995-2008.
Wilson RJ; O'Neil ME; Ntekop E; Zhang K; Ren Y
J Registry Manag; 2014; 41(2):65-71; quiz 96-7. PubMed ID: 25153011
[TBL] [Abstract][Full Text] [Related]
15. Feasibility study for collection of HER2 data by National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results (SEER) Program central cancer registries.
Reichman ME; Altekruse S; Li CI; Chen VW; Deapen D; Potts M; Wu XC; Morrell D; Hafterson J; Phipps AI; Harlan LC; Ries LG; Edwards BK
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):144-7. PubMed ID: 20056633
[TBL] [Abstract][Full Text] [Related]
16. Are cancer survivors willing to participate in research?
Geller BM; Mace J; Vacek P; Johnson A; Lamer C; Cranmer D
J Community Health; 2011 Oct; 36(5):772-8. PubMed ID: 21311959
[TBL] [Abstract][Full Text] [Related]
17. Potential of Using Twitter to Recruit Cancer Survivors and Their Willingness to Participate in Nutrition Research and Web-Based Interventions: A Cross-Sectional Study.
Keaver L; McGough A; Du M; Chang W; Chomitz V; Allen JD; Attai DJ; Gualtieri L; Zhang FF
JMIR Cancer; 2019 May; 5(1):e7850. PubMed ID: 31140436
[TBL] [Abstract][Full Text] [Related]
18. End-of-life care for lung cancer patients in the United States and Ontario.
Warren JL; Barbera L; Bremner KE; Yabroff KR; Hoch JS; Barrett MJ; Luo J; Krahn MD
J Natl Cancer Inst; 2011 Jun; 103(11):853-62. PubMed ID: 21593012
[TBL] [Abstract][Full Text] [Related]
19. Connect MM Registry as a national reference for United States multiple myeloma patients.
Ailawadhi S; Jagannath S; Narang M; Rifkin RM; Terebelo HR; Toomey K; Durie BGM; Hardin JW; Gasparetto CJ; Wagner L; Omel JL; Kumar V; Yue L; Kitali A; Agarwal A; Abonour R;
Cancer Med; 2020 Jan; 9(1):35-42. PubMed ID: 31701679
[TBL] [Abstract][Full Text] [Related]
20. Assessing the quality of race/ethnicity, tumor, and breast cancer treatment information in a non-SEER state registry.
Silva A; Rauscher GH; Ferrans CE; Hoskins K; Rao R
J Registry Manag; 2014; 41(1):24-30. PubMed ID: 24893185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
